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Identification of Amino Acid Residues
that Control Functional Behavior
in GluR5 and GluR6 Kainate Receptors
Geoffrey T. Swanson,* Robert W. Gereau IV, tinct currents from AMPA and kainate receptors (Som-
mer et al., 1990; Sommer et al., 1992; KoÈ hler et al., 1993).Tim Green, and Stephen F. Heinemann
In combination with differential sensitivities to allostericMolecular Neurobiology Laboratory
modulators such as cyclothiazide, concanavalin A, andThe Salk Institute
GYKI 53655 (Partin et al., 1993; Wilding and Huettner,10010 North Torrey Pines Road
1995), this divergent pharmacology has proven usefulLa Jolla, California 92037
for identifying receptor types underlying responses in
neurons and glia (Lerma et al., 1993; Partin et al., 1993;
Patneau et al., 1994; Puchalski et al., 1994; Wilding and
Summary Huettner, 1997).
Agonist-binding affinities and response characteristics
GluR5 and GluR6 kainate receptors differ in their re- also have been used as a tool for exploring the mem-
sponses to a variety of agonists, despite their relatively brane topology and agonist-binding domain of non-
high primary sequence homology. We carried out a NMDA receptors. A divergence in function and agonist
structure±function study to identify amino acids un- sensitivity of AMPA and kainate receptors is observed
derlying these divergent responses. Patch clamp anal- with agonists such as AMPA, kainate, and domoate
ysis of chimeric GluR5-GluR6 receptors indicated that (Hollmann and Heinemann, 1994). Using agonist-binding
several functionally dominant sites were localized to affinities of GluR3-GluR6 chimeric subunit proteins,
the C-terminal side of M1. All nonconserved amino Stern-Bach et al. (1994) mapped the ligand-binding do-
acids in the region between M3 and M4 of GluR6 were main to two regions they termed S1 and S2, which pre-
then individually mutated to their GluR5 counterparts. cede M1 and follow M3, respectively. Their results sup-
We found that a single amino acid (N721 in GluR6) ported other studies that proposed a new topology for
controls both AMPA sensitivity and domoate deactiva- glutamate receptors that modeled the second hydro-
tion rates. Additionally, mutation of A689 in GluR6 phobic region as a reentrant loop rather than a mem-
slowed kainate desensitization. These functional ef- brane-spanning helix (Hollmann et al., 1994; Wo and
fects were accompanied by alterations in binding af- Oswald, 1994; Bennett and Dingledine, 1995). This model
finities. These results support a critical role for these therefore predicts that the region between the end of
M3 and the beginning of M4, which includes the S2residues in receptor binding and gating activity.
domain, is located on theextracellular side of theplasma
membrane. While the GluR3-GluR6 chimeras identifiedIntroduction
macrodomains involved in binding, interpretation of
changes to agonist response kinetics was problematicIonotropic glutamate receptor subunits constitute a
in these cross-family (AMPA/kainate) chimeras, particu-large family of ligand-gated ion channels responsible
larly since a number of chimeras were nonfunctionalfor the majority of excitatory synaptic transmission in
(Stern-Bach et al., 1994). Screening of the agonist-bind-the central nervous system. This gene family is subdi-
ing domain of glutamate receptors using site mutagene-vided into non-NMDA and NMDA receptor subunits,
sis has also determined that a limited number of amino
which underlie the fast and slow component of excit-
acids in the S1 and S2 regions control binding affinity
atory transmission, respectively. Characterization of the
to NMDA receptors and chick kainate-binding proteins
nine cloned non-NMDA receptor subunits has identified (KBP) (Kuryatov et al., 1994; Paas et al., 1996; Laube et
two subfamilies, a-amino-3-hydroxy-5-methyl-4-isoxa- al., 1997).
zolepropionic acid (AMPA) preferring (GluR1±4) and kai- In the current study, we have examined residues in-
nate preferring (GluR5±7, KA-1 and KA-2) (Hollmann and volved in both binding and gating by making receptor
Heinemann, 1994). Despite z40% amino acid sequence chimeras and restricted amino acid mutations to two
homology, AMPA receptor subunits do not coassemble highly homologous kainate receptor subunits, GluR5
with kainate receptors (Brose et al., 1994; Patneau et and GluR6. These subunits are 80% identical at the
al., 1994; Puchalski et al., 1994; Wenthold et al., 1994), amino acid level, with the least conserved domains
and these receptor subfamilies exhibit different agonist found in the N- and C-terminal regions (Bettler et al.,
affinities and response kinetics (Hollmann and Heine- 1990; Egebjerg et al., 1991). While the responses to
mann, 1994). However, expression and functional char- glutamate are qualitatively similar in these subunits,
acterization of cloned AMPA and kainate receptors have those to kainate, AMPA, and the high affinity agonist
revealed a strong similarity in their response to the en- domoate are quite distinct (Sommer et al., 1992; KoÈ hler
dogenous neurotransmitter glutamate. All functional et al., 1993). GluR5 receptors desensitize slowly in the
non-NMDA subunits cloned to date respond to fast ap- presence of kainate, while GluR6 receptors show rapid
plied glutamate at high concentration (mimicking synap- and nearly complete desensitization. With domoate,
both desensitization rates and current decay rates aftertic transmission) with rapid activation and desensitiza-
removal of agonist differ between GluR5 and GluR6.tion (Sommer et al., 1992; KoÈ hler et al., 1993; Mosbacher
Finally, GluR5 is activated by high concentrations ofet al., 1994). In contrast, other agonists elicit quite dis-
AMPA, whereas GluR6 is completely insensitive to this
compound. These differences in agonist response char-
acteristics were used as an assay for localization of*To whom correspondence should be addressed.
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Figure 1. Comparison of Representative Ag-
onist-Evoked Currents from GluR5 (A) and
GluR6 (B) Receptors
The inset response in (A) is an example of a
fast desensitizing kainate response in GluR5;
this type of response was relatively rare.
Drugs were applied during the time indicated
by the gray bar under the following condi-
tions: 1 mM kainate for 1 s, 30 mM domoate
for 1 s, 500 mM AMPA for 100 ms, and 1 mM
glutamate for 100 ms. The holding potential
was 270 mV in each case.
residues that play a role in binding and/or gating pro- is representative of the majority of kainate-evoked cur-
rents we observed in GluR5-expressing cells, in that acesses in these receptors. We initially constructed chi-
meras to localize important domains of the proteins that mixture of both fast and slow components was ob-
served; the slower desensitizing component predomi-regulate channel kinetics, then proceeded with single
and multiple site mutation of amino acids that vary nated in all but a few examples. Three cells (out of 18)
showed a predominant fast desensitizing componentamong the subunits. Fast application of agonists al-
lowed us to resolve nondesensitized peak currents and like that shown in the inset kainate response in Figure
1A (tfast 5 1.4 ms and tslow 5 17.2 ms for inset response).construct a detailed description of the kinetic behavior
of the receptor chimeras and mutants. We report the The mechanism that underlies the variability in the GluR5
response to kainate remains unclear. In contrast, kainatecharacterization of two sites that control aspects of
binding and functional properties of GluR5 and GluR6 consistently evoked rapidly desensitizing currents from
GluR6 receptors (t 5 4.4 6 0.3 ms [mean 6 SEM]; n 5kainate receptors.
11; Figure 1B); steady-state currents were 1.22% 6
0.03% of peak currents with this agonist. Domoate acti-Results
vates slowly desensitizing currents in GluR5 channels
and rapidly desensitizing currents in GluR6 but, moreWe first characterized those channel properties that
would be useful for mapping the binding and gating interestingly, has an z7-fold slower deactivation rate in
GluR6 compared to GluR5 (Figures 1A and 1B). Thedomains in GluR5 and GluR6 by analyzing their current
kinetics after expression in HEK 293 cells. Consistent decay rates of the currents after removal of domoate
were best fitted with two exponential components forwith previous reports, we found that GluR5 and GluR6
differ in aspects of their responses to kainate, domoate, both receptors: for GluR5, t1 5 0.15 6 0.11 s and t2 5
0.65 6 0.24 s (relative proportions of 58.4% and 41.6%;and AMPA (Figure 1 and Table 1) (Sommer et al., 1992;
KoÈ hler et al., 1993). In GluR5-expressing cells, kainate n 5 9), whereas for GluR6, t1 5 1.05 6 0.1 s and t2 5
4.79 6 0.48 s (relative proportions of 60.7% and 39.3%;(1 mM) activatedcurrents with extremely variable desen-
sitization rates (tdes values ranged from 1.5 ms to .3 s; n 5 12). AMPA does not gate currents in homomeric
GluR6, whereasGluR5 has low but detectable sensitivityn 5 18). An example of a slowly desensitizing kainate
response is shown in Figure 1A. This type of response to AMPA (mean current amplitude with 500 mM AMPA
Kainate Receptor Structure±Function
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Table 1. Functional Properties of Kainate Receptors, Chimeras, and GluR6 Site Mutants
Kainate Glutamate Domoate AMPA
Receptor ipeak (nA) tdes (ms) ipeak (nA) tdes (ms) ipeak (nA) tdec1 (sec) tdec2 (sec) ipeak (pA)
GluR5 0.57 6 0.08 variable 0.63 6 0.16 4.1 6 0.9 0.33 6 0.07 0.15 6 0.11 0.65 6 0.24 111 6 45
(18) (5) (9) (5)
GluR6 3.4 6 0.6 4.4 6 0.3 4.4 6 1.0 4.1 6 0.2 1.5 6 0.3 1.05 6 0.10 4.79 6 0.48 ND
(12) (9) (12) (13)
R6tm1R5 0.75 6 0.20 variable 0.53 6 0.14 8.3 6 1.1 0.39 6 0.11 0.21 6 0.03 0.79 6 0.09 52 6 10
(10) (10) (9) (9)
R5tm1R6 0.45 6 0.08 2.1 6 0.2 0.53 6 0.14 3.3 6 0.7 0.13 6 0.12 0.33 6 0.08 ND ND
(7) (6) (7) (8)
R6(E686R) 1.8 6 0.4 4.4 6 0.5 1.9 6 0.3 4.8 6 0.5 0.80 6 0.21 1.03 6 0.23 5.50 6 1.31 ND
(9) (7) (8) (9)
R6(A689S) 3.2 6 2.2 10.2 6 1.4 3.5 6 2.3 5.8 6 1.4 1.6 6 1.4 0.93 6 0.39 3.68 6 1.56 ND
(8) (6) (8) (8)
R6(D703E) 3.0 6 0.5 4.1 6 0.3 3.7 6 0.4 4.4 6 0.6 1.6 6 0.3 1.03 6 0.12 4.45 6 0.45 ND
(6) (5) (5) (6)
R6(R713Q) 4.3 6 0.5 5.0 6 0.3 4.9 6 0.5 5.9 6 0.5 1.4 6 0.4 0.75 6 0.09 3.42 6 0.58 ND
(9) (8) (8) (9)
R6(V716A) 2.8 6 0.4 4.6 6 0.5 2.7 6 0.3 5.2 6 0.9 0.72 6 0.14 0.85 6 0.07 4.02 6 0.41 ND
(7) (5) (7) (6)
R6(S720N) 5.0 6 0.8 5.2 6 0.6 5.6 6 0.9 5.3 6 0.7 3.2 6 0.7 1.04 6 0.13 5.53 6 1.14 ND
(9) (8) (9) (6)
R6(N721S) 3.3 6 0.5 4.9 6 0.4 3.4 6 0.6 3.5 6 0.3 1.2 6 0.3 0.22 6 0.03 1.33 6 0.36 287 6 108
(11) (7) (8) (11)
R6(E722D) 3.9 6 0.7 5.0 6 0.3 1.8 6 0.6 3.4 6 0.2 1.2 6 0.3 0.86 6 0.07 3.76 6 0.58 ND
(9) (8) (9) (9)
R6(S731T) 2.9 6 0.5 4.1 6 0.2 3.5 6 0.5 4.2 6 0.2 1.1 6 0.2 1.32 6 0.18 4.28 6 0.61 ND
(10) (6) (8) (10)
R6(F735L) 1.6 6 0.4 6.8 6 0.7 2.7 6 1.1 6.0 6 0.9 0.49 6 0.12 0.62 6 0.07 2.64 6 0.45 ND
(11) (5) (10) (8)
R6(T741S) 3.6 6 0.5 4.6 6 0.5 5.2 6 1.3 4.3 6 0.1 1.1 6 0.3 1.50 6 0.14 7.63 6 1.35 ND
(6) (4) (5) (5)
R6(F744Y) 3.4 6 0.5 4.4 6 0.5 3.7 6 0.7 4.3 6 0.4 1.8 6 0.2 1.49 6 0.10 6.42 6 0.55 ND
(7) (5) (8) (6)
R6(M770I) 2.7 6 0.5 3.7 6 0.3 3.5 6 0.8 3.5 6 0.9 2.3 6 0.6 1.25 6 0.26 5.13 6 0.68 ND
(9) (5) (7) (9)
R6(E808D) 2.9 6 0.4 3.3 6 0.3 3.4 6 0.3 3.3 6 0.2 1.6 6 0.4 0.91 6 0.11 3.76 6 0.58 ND
(6) (6) (8) (8)
R6(Q818E) 3.6 6 0.7 4.1 6 0.3 3.6 6 0.7 3.9 6 0.3 2.1 6 0.5 1.11 6 0.10 5.02 6 0.79 ND
(5) (5) (6) (6)
R6(689/721) 3.8 6 0.4 8.1 6 0.9 3.6 6 0.5 4.5 6 0.6 3.1 6 1.0 0.30 6 0.05 1.31 6 0.33 81 6 41
(8) (8) (6) (3)
All receptors were expressed in HEK 293 cells, and currents were recorded using whole-cell patch clamp. For each receptor and agonist
application, the number of cells is shown in parentheses under the mean and SEM values. For the R6 mutants, kinetic properties that are
statistically different (p , 0.05) from those of GluR6 are shown in bold italics.
was 111 6 45 pA; n 5 5). On GluR5, AMPA also activated with either the N- or C-terminal half of the receptor
proteins. Chimera R6tm1R5 was composed of GluR6currents with variable desensitization kinetics. Gluta-
mate activated rapidly desensitizing currents in both sequence up to the start of M1, followed by GluR5 se-
quence through to the C terminus (Figure 2A). The iso-receptor types (GluR5, 4.1 6 2.0 ms; n 5 5; GluR6, 4.1 6
0.2 ms; n 5 9). While the mechanisms underlying the form of GluR5 utilized to construct the chimera was
striking variability of GluR5 desensitization rates are un- GluR5±2a (Sommer et al., 1992). The R6tm1R5 construct
clear, our observations are similar to those recently re- therefore had an S1 domain from GluR6 and an S2 do-
ported for glutamate-activated GluR6 currents in out- main from GluR5. The converse arrangement of subunit
side-out patches (Heckmann et al., 1996; Bufler et al., sequence was generated in chimera R5tm1R6, in which
1997). Because of the variability inGluR5 desensitization the N-terminal half of GluR5 was spliced onto the
rates observed with kainate, we chose to focus primarily C-terminal half of GluR6 (Figure 2B). All receptors and
on the differences in AMPA sensitivity and domoate chimeras had a glutamine at the Q/R site in the reentrant
deactivation rates as diagnostic assays for important loop region (denoted M2). Each chimera was tested for
functional domains of the receptors. responses to four agonists at single concentrations: 500
mM AMPA, 30 mM domoate, 1 mM kainate, and 1 mM
glutamate. Both chimeras expressed functional chan-Functional Properties of Kainate
nels in HEK 293 cells (Figures 2A and 2B).Receptor Chimeras
R6tm1R5 produced channels with currents similar butTwo chimeric kainate receptor subunits were con-
not identical to those of GluR5 for AMPA, domoate, andstructed to resolve whether determinants of the diver-
gent agonist responses could be specifically associated kainate (Figure 2A). The channel was sensitive to AMPA,
Neuron
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Figure 2. Comparison of Representative Ago-
nist-Evoked Currents from Chimeras R6tm1R5
(A) and R5tm1R6 (B)
The orientations of the chimeras are shown in
the cartoons above the corresponding re-
sponses. GluR5 domains are represented in
white and GluR6 in gray, and membrane-span-
ningdomains are shown as larger boxes. Drugs
were applied during the time indicated by the
gray bar under the following conditions: 1 mM
kainate for 100 ms, 30 mM domoate for 1 s,
500 mM AMPA for 200 ms (GluR5) or 1 mM
AMPA for 100 ms (GluR6), and 1 mM glutamate
for 100 ms. The holding potential was 270 mV
in each case.
responding with a small, desensitizing current (52 6 10 rate at which we can apply the agonists (10%±90% rise
times of the R5tm1R6 currents were 1.1 6 0.1 ms withpA; n 5 9). Domoate elicited a desensitizing current
with a deactivation rate that was best fitted with two kainate and 1.5 6 0.2 ms for glutamate). Domoate gave
very small responses with variable desensitization kinet-exponential components (t1 5 0.21 6 0.03 s and t2 5
0.79 6 0.09 s; n 5 9). These values are not significantly ics in R5tm1R6. Because of the small amplitude of the
currents, the deactivation kinetics were difficult to ana-different from those of GluR5 (p 5 0.20, unpaired t test).
In nine cells, R6tm1R5 kainate currents desensitized lyze, and time constants were likely to be underesti-
mated. Only a single exponential component could besomewhat faster than seen for GluR5 but were still an
order of magnitude slower than GluR6 kainate desensiti- fitted to the data (t 5 0.33 6 0.08 s; n 5 7).
The functional behavior of these M1 chimeras giveszation (e.g., compare kainate currents in Figures 1 and
2). Lastly, 1 mM glutamate gave a rapidly activating and at least one clear example of delineation of agonistprop-
erties by a single half of the receptor protein: that ofdesensitizing current with variable kinetics (mean 8.3 6
1.1 ms; n 5 10). low affinity AMPA sensitivity. AMPA sensitivity appears
to correlate with the subunit type comprising the S2Chimera R5tm1R6 gave channels whose functional
properties were similar to those of GluR6 (Figure 2B) domain of the kainate receptors. While these chimeras
do not exclude participation of residues further down-with some differences in the responses to glutamate
and kainate. No AMPA-evoked currents were detected stream than S2, strong evidence suggests that S2 is
critical for determining the binding properties of iono-in eight cells transfected with this chimera (tested at 1
mM AMPA). Both kainate and glutamate gave rapidly tropic glutamate receptors (Stern-Bach et al., 1994). We
therefore focused on amino acid residues in the S2 re-desensitizing currents. The kainate desensitization rate
for R5tm1R6 was significantly faster than that of GluR6 gion as possible determinants of the functional differ-
ences between GluR5 and GluR6.(t 5 2.1 6 0.2 ms; n 5 7 versus 4.4 6 0.3 ms; p , 0.01).
The R5tm1R6 glutamate desensitization rate had a t of
3.3 6 0.7 ms(n 5 6) as compared to 4.1 6 0.2 ms for GluR6 Control of Kainate Receptor AMPA Sensitivity
by a Single Residue in the S2 Domain(not significantly different; p 5 0.20). These R5tm1R6
desensitization kinetics are likely tobe somewhat slower In the region between M3 and M4, GluR5 and GluR6
share 91% identity in their amino acid sequence. In orderthan the actual rates due to technical limitations in the
Kainate Receptor Structure±Function
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Figure 3. Comparison of GluR5 and GluR6 Amino Acid Sequences in the Region of the Subunit Proteins between M3 and M4 (A) and AMPA
Currents in GluR5, GluR6, and Selected Mutants (B and C)
(A) A sequence alignment of GluR5 and GluR6, with only those residues in GluR6 that differ from GluR5 shown on the lower line. The numbering
is from the start of the signal peptide. Two regions of complete homology have been omitted. The numbers in bold (720 and 721) indicate sites of
mutation for the currents shown in the bottom panel.
(B) Currents evoked by application of AMPA to HEK cells expressing GluR6, R6(N721S), and R6(S720N).
(C) Currents evoked by application of AMPA to HEK cells expressing GluR5, R5(S721N), and R5(N720S). The gray bars mark the 200 ms applications.
The AMPA concentration was 500 mM in most cases and 1 mM for R5(S721N). The holding potential was 270 mV in each case. The calibration
bars are: x-axis, 40 ms for GluR6, R6(S720N), GluR5, R5(S721N), and R5(N720S) and 80 ms for R6(N721S); y-axis, 150 pA for all traces.
to determine which specific residue(s) in this domain 2.5% of the peak glutamate current in cells where both
agonists were tested (n 5 7), as compared to 17.6% 6underlie the differing sensitivity to AMPA, we made sin-
gle-site mutations to all 15 nonconserved amino acids 3.6% in GluR5 (n 5 5). R6(N721S) AMPA currents pre-
dominantly desensitized with a t ≈ 12 ms, but theseto convert the native GluR6 amino acid to the corre-
sponding GluR5 residue. Selected GluR5 mutants were kinetics showed a great deal of variability. Two cells had
a double exponential desensitization rate with a sloweralso made to test whether alterations in current kinetics
resulting from GluR6 mutations had reciprocal effects t . 100 ms. These current characteristics are similar to
those seen when AMPA is applied to GluR5 and differon GluR5. In reporting these results, we have numbered
amino acids in GluR5 and GluR6 starting with their signal considerably from the AMPA currents gated by GluR6/
KA-2 heteromers (Herb et al., 1992), which consistentlypeptides; note also that GluR5±2a does not contain the
N-terminal insertion as reported in GenBank (see Experi- desensitize very slowly.
From the analysis of the GluR6 mutants, it appearedmental Procedures). All single- and multiple-site GluR6
and GluR5 mutants were tested with the same battery of that amino acid N721 was the primary determinant of
AMPA sensitivity in kainate receptors. If this is the case,agonists as used with the chimeras, and all site mutants
were functional. then the complementary serine-to-asparagine mutation
in GluR5 should eliminate AMPA-gated currents. AsAs shown in Table 1, a single GluR6 S2 site mutant,
R6(N721S), was sensitive to AMPA. All other GluR6 site shown in Figure 3C and Table 1, R5(S721N) was insensi-
tive to AMPA (n 5 6) (middle trace, Figure 3C), while itsmutants failed to gate currents during fast application
of 500 mM AMPA. R6(N721S) had AMPA-gated currents neighboring mutation, R5(N720S), showed no significant
reduction in AMPA currents as compared to nativewith a mean amplitude of 287 6 108 pA (n 5 11). Figure
3B shows example traces of AMPA application to native GluR5 (top and bottom traces, Figure 3C). Thus, S721
seems to be necessary to generate low affinity AMPAGluR6, R6(N721S), and its neighboring mutation site,
R6(S720N). The AMPA currents activated slowly com- currents in these kainate receptors.
pared to kainate and glutamate (10%±90% rise time of
3.3 6 0.3 ms for AMPA and 1.2 6 0.1 ms for kainate and Amino Acid N721 Also Controls the Rate of Channel
Deactivation after Application of Domoateglutamate), most probably because the concentration of
AMPA used was lower than the peak EC50, which has R6(N721S) responses to domoate also exhibited a deac-
tivation rate that was closer to that of GluR5 (Figuresbeen estimated at 3 mM for GluR5 (Sommer et al., 1992).
The peak AMPA current seen for R6(N721S) was 8.0% 6 4A and 4B), while the domoate desensitization rate and
Neuron
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Figure 4. Domoate-Evoked Currents in GluR6 and Mutants (A and B) and Comparison of Deactivation Rates for GluR5, GluR6, and all GluR6
Mutants (C)
(A) Currents evoked by application of 30 mM domoate to HEK cells expressing GluR6, R6(N721S), and R6(A689S). The holding potential was 270
mV in each case.
(B) Comparison of deactivation rates after removal of domoate from GluR6 and R6(N721S) traces shown in (A). The deactivation rate constants for
the currents shown were 0.24 and 1.45 s for R6(N721S) and 1.33 and 5.89 s for GluR6.
(C) Plot of the mean fast versus slow deactivation rate constants for GluR5, GluR6, and all GluR6 mutants; in the top panel, the mutants are
identified, and in the bottom, the SEM bars are shown. GluR6, R6(N721S), and R6(A689S) are shown as closed squares and highlighted in bold.
glutamate and kainate responses were similar to that of by the rate at which ligand unbinds from the receptor
complex. For both R5 and R6, this deactivation rate wasGluR6 (Table 1). The R6(N721S) current decay rate after
removal of domoate was best fitted with twoexponential best fitted as a multiexponential process. To illustrate
the clear separation of the R6-type mutants from thecomponents: t1 5 0.22 6 0.03 s and t2 5 1.33 6 0.36 s
(representing 58% and 42% of the exponential decay, R5-like mutants, in Figure 4C we have plotted the slower
versus faster mean t values for GluR5, GluR6, and allrespectively; n 5 8). This is significantly different from
the domoate deactivation from GluR6 (p , 0.005) but the GluR6 mutants. (In the figure, the top graph identifies
themutants, and thebottom graph shows the SEMasso-not statistically different from GluR5 deactivation rates
(p 5 0.154). Figure 4A shows examples of domoate ap- ciated with each data point). R6(N721S) and the double
mutant R6(N721S/A689S) were the only two mutantsplication to native GluR6, R6(N721S), and R6(A689S),
and deactivation currents are shown on an expanded that had deactivation rate components that were both
significantly different from GluR6 and indistinguishablescale in Figure 4B. As is apparent from the figure, desen-
sitization rates are relatively unchanged in R6(N721S), from GluR5. An additional mutant, R6(F735L), had a do-
moate deactivation rate intermediate to that of R5 andbut the current decays much faster after removal of
domoate. R6(A689S) was of interest, as it exhibits slowed R6 (t1 5 0.62 6 0.07 s and t2 5 2.64 6 0.45 s; n 5 10);
both exponential components were significantly differ-desensitization rates during application of kainate but
no alteration in its response to domoate, glutamate, or ent than GluR5 and GluR6 (p , 0.05). R6(F735L) currents
were on average z50% smaller than currents fromAMPA (see Figure 6). Domoate deactivation rates for the
double mutant R6(A689S/S721N) were indistinguishable GluR6 and other mutants. As is evident from the figure,
there is a strong linear relationship between the fast andfrom R6(N721S) (data not shown) as were its fast desen-
sitizing AMPA responses, demonstrating that amino slow deactivation components of the kainate receptor
mutants (r 5 0.95).acid N721 controls aspects of the kinetic response to
domoate. Domoate deactivation kinetics in R5(S721N), the GluR5
mutant complementary to R6(N721S), were significantlyThe time course of receptor deactivation after removal
of domoate (subsequent to a prolonged application) re- slower than native GluR5. Figure 5A shows examples
of responses from GluR5 and three mutants: R5(S721N),flects the closure of open channels that are in equilib-
rium with one or more closed states and is also affected the complementary mutation to R6(N721S), R5(S689A),
Kainate Receptor Structure±Function
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Figure 5. Domoate-Evoked Currents in GluR5
and Mutants (A and B) and Comparison of
Deactivation Rates for GluR5, R5(S689A),
R5(N720S), R5(S721N), and GluR6 (C)
(A) Currents evoked by application of 30 mM
domoate to HEK cells expressing GluR5,
R5(S721N), R5(S689A), and R5(N720S). The
holding potential was 270 mV in each case.
(B) Comparison of deactivation rates after re-
moval of domoate from GluR5, R5(S689A),
and R6(S721N) traces shown in (A). The deac-
tivation rate constants for the currents shown
were 45 and 189 ms for R5(S689A), 166 and
754 ms for GluR5, and 481 ms and 11.5 s for
R5(S721N).
(C) Plot of the mean fast deactivation rate
constant for GluR5, the mutants shown in (A),
and GluR6. Error bars indicate the SEM. A
single asterisk denotes statistically signifi-
cant difference from GluR5 of p , 0.05, and
a double asterisk denotes a significance of
p , 0.001. See Table 1 for the number of cells
for each receptor.
and a mutant with normal kinetics, R5(N720S). The de- Slowing of Kainate Desensitization Rates
with Mutation of Amino Acid A689cay currents after removal of agonist are isolated and
normalized in Figure 5B to compare directly their time Unlike AMPA sensitivity and domoate deactivation
rates, no single amino acid mutation in the M3-M4 linkercourses. Deactivation of R5(S721N) after removal of do-
moate were in most cases best fitted with a single expo- region of GluR6 altered the kainate-activated current
desensitization properties to a rate resembling that ofnential with a t 5 0.55 6 0.02 s (n 5 5). One R5(S721N)
cell could only be fitted with the sum of two exponential GluR5. However, mutation of A689 to a serine residue
generated a channel with a significantly slower desen-components, with t1 5 0.17 s and t2 5 1.48 s (68% and
32% of the current, respectively). We compared this sitization rate during application of kainate. Figure 6A
shows examples of kainate applications to GluR6, R6single-exponential deactivation to the faster (and pre-
dominant) deactivation component of GluR5, the other (A689S), R6(N721S), and R6(A689S/N721S). In R6(A689S),
desensitizing kainate currents were best fitted with theGluR5 mutants, and GluR6. As shown in Figure 5C, the
R5(S721N) deactivation rate is significantly slower than sum of two exponential components with t1 5 8.7 6 2.2
ms and t2 5 108 6 36 ms (proportionally 92% and 8%predominant deactivation component of GluR5 and the
two other GluR5 mutants but still somewhat faster than of the exponential decay, respectively; n 5 6). The acti-
vation rate for R6(A689S) with kainate was indistinguish-the predominant deactivation rate for GluR6. It should
be noted that R5(S721N) domoate currents were smaller able from that of GluR6 (10%±90% rise time of 1.4 6
0.1 ms for both receptors). The effect of this mutation onthan those from GluR5, and our ability to measure the
deactivation rate was hampered by current noise in a current properties is specific for kainate, as R6(A689S)
responses to domoate and glutamate were similar tosimilar manner to chimera R5tm1R6. We therefore can-
not rule out the possibility that R5(S721N) may have a native GluR6 (see Figure 4 and Table 1). Furthermore,
addition of a mutation at N721 does not alter the slowerslower, unresolved exponential component in the cur-
rent deactivation. Despite this uncertainty, these data kainate desensitization of R6(A689S), as the double mu-
tants R6(A689S/N721S) had kainate responses similardemonstrate that mutation of R6(N721) and R5(S721)
had at least partially reciprocal effects on domoate cur- to those of R6(A689S): t1 5 8.1 6 0.9 ms and t2 5 61 6
12 ms (n 5 8) (Figure 6B). These results demonstraterents in GluR5 and GluR6.
Interestingly, mutation of S689 in GluR5 increased the that mutation of A689 in GluR6 specifically affects the
kainate response, while mutation of N721 alters the re-rate of domoate current deactivation (predominant t 5
56 6 15 ms; n 5 7; see Figure 5); this contrasts with the sponse to domoate and AMPA.
One other GluR6 mutant had an altered kainate desen-lack of effect on deactivation rates after mutation of the
corresponding amino acid in GluR6 (A689). In the double sitization rate as compared towild typeÐR6(F735L) (Fig-
ure 6B). This mutant receptor had a tdes 5 6.8 6 0.7mutant R5(S689A/S721N), for which deactivation was
best fitted with a single exponential component, do- ms with kainate, which was significantly different from
GluR6 (p , 0.005; n 5 11). It is possible that the slowermoate deactivation rates were not significantly different
than native GluR5 (t 5 0.26 6 0.09 s; n 5 4), indicating desensitization rates seen with this mutant reflect an
alteration in the concentration dependence of the re-that both sites may play a role in determining the current
deactivation rate in GluR5 or that there may be other sponses, as the current amplitudes with R6(F735L) are
roughly half that of GluR6. Furthermore, the activationinteracting residues.
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Figure 6. Kainate-Evoked Currents in GluR6
and Selected Mutants (A) and Comparison of
Desensitization Rates for GluR6 and All R6
Mutants (B)
(A) Currents evoked by application of 1
mM kainate to HEK cells expressing GluR6,
R6(A689S), R6(N721S), and R6(A689S/N721S).
The holding potential was 270 mV in each
case.
(B) Plot of the mean desensitization rates for
GluR6 and R6 mutants shown in (A). Error
bars indicate the SEM. A single asterisk de-
notes statistical significance of p , 0.05, and
a double asterisk denotes a significance of
p , 0.001. See Table 1 for the number of cells
for each receptor.
rates are slower in R6(F735L) as compared to GluR6 was somewhat lower than they reported (36 nM; Lomeli
et al., 1992).(1.7 6 0.1 ms versus 1.4 6 0.1 ms for GluR6; n 5 11
and 12, respectively). Since the effects on domoate de- Mutation of A689 and N721 in GluR6 reduced the
kainate-binding affinity by approximately 2- and 5-fold,activation rates and the kainate desensitization rates
are not as substantial with this mutant as with R6(A689S) respectively, and altered displacement by glutamate,
domoate, and AMPA to different degrees (Figure 7). Forand R6(N721S), and R6(F735L) does not gate AMPA
currents, the role that this residue plays in ligand binding R6(A689S), the KD for kainate was 29.1 6 4.5 nM, and
the Ki values for domoate and glutamate were 7.7 6 4.3and gating is unclear. However, it is possible that a more
detailed examination of this particular mutant may prove nM (n 5 3) and 239 6 49 nM (n 5 3), respectively.
As with GluR6, AMPA gave very little displacement ofinteresting.
[3H]kainate from R6(A689S) (,25% displacement at 250
mM; n 5 3). For R6(N721S), the KD for kainate was 62.0 6Effects of A689 and N721 Mutations
on [3H]Kainate Binding 10.6 nM, and the Ki values for domoate and glutamate
were 27.4 6 1.3 nM and 214 6 72 nM (n 5 3 and 4,In order to determine if the selectivity in agonist function
is reflected by selectivity in agonist binding, the binding respectively). AMPA displaced [3H]kainate binding to
R6(N721S) with a Ki value of 16 6 6 mM. Therefore,properties of R6(A689S) and R6(N721S) were examined.
Previously reported KD values for kainate binding to these binding results correlate with the most striking
functional effect of the R6(N721S) mutation, generationGluR6 have ranged from 13 nM (Tygesen et al., 1995) to
100 nM (Stern-Bach et al., 1994) (in different expression of AMPA sensitivity. The fact that the measured
R6(N721S) Ki of 16 mM does not entirely match the AMPAsystems). In HEK 293 cells, the kainate affinity for GluR5
is lower than that for GluR6 (GluR5 KD 5 73 nM; GluR6 affinity for GluR5 (3 mM) may reflect the presence of
additional sites that affect the AMPA-binding affinity orKD 5 36 nM) (Lomeli et al., 1992). Ki values for other
agonists aregenerally similar between GluR5and GluR6; may be a result of inaccuracy in the analysis of this low
affinity site.the greatest differences are found in the Ki values for
domoate (4-fold less potent on GluR6) and the lack of
displacement by AMPA on GluR6 (Lomeli et al., 1992). Discussion
We first assayed the binding properties of wild-type
GluR6, which seemed necessary given the variability in By making single amino acid substitutions between GluR5
and GluR6 and recording the agonist-evoked currentsreported affinities. As shown in Figure 7 and Table 2,
kainate had a KD of 13.1 6 1.7 nM (n 5 3) in our assays, with high resolution, we have identified two amino acids
that control aspects of the binding and functional re-and Ki values for domoate and glutamate were 10.7 6
2.9 nM (n 5 4) and 556 6 150 nM (n 5 3), respectively. sponses of these kainate receptors. Mutation of aspara-
gine 721 in GluR6 to a serine, the corresponding residueAMPA gave very little displacement of [3H]kainate from
GluR6 (,25% displacement at 250 mM; n 5 3). These in GluR5, created an AMPA-sensitive GluR6 receptor
that also had a domoate deactivation rate indistinguish-values are similar to those reported by Lomeli et al.
(1992), with the exception of the KD for kainate, which able from that of GluR5. Mutation of all other residues
Kainate Receptor Structure±Function
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Figure 7. Binding Properties of GluR6, R6(A689S), and R6(N721S)
(A) Representative Scatchard plots calculated from the [3H]kainate-binding isotherms using membranes prepared from HEK cells expressing
GluR6 (closed squares), R6(A689S) (closed circles), and R6(N721S) (closed triangles). Nonspecific binding was determined in the presence of
100 mM kainate. Scatchards were normalized on both axes to facilitate comparison of binding affinities.
(B) Representative glutamate displacement curves for the three receptors.
(C) Representative AMPA displacement curves for the three receptors.
(D) Representative domoate displacement curves for the three receptors. In the displacement experiments, the concentration of [3H]kainate
was 5 nM for GluR6 and R6(A689S) and 10 or 15 nM for R6(N721S). Mean KD and Ki values are given in Table 2.
that differed between GluR5 and GluR6 in the extracellu- amino acids are involved in the receptor-specific re-
sponse to different agonists. Our results provide furtherlar region between M3 and M4 had no effect on the
AMPA sensitivity of the GluR6 channels, suggesting that insight into the structural makeup of the agonist-binding
domain of ionotropic glutamate receptors.these functional alterations are unlikely to be due to
gross disruption of the tertiary structure of the protein.
Additionally, mutation of alanine 689 to serine markedly Comparison with Previous Structure±Function Studies
Our current study complements and extends previousslowed GluR6 desensitization rates. Mutation of N721
decreased the binding affinities of kainate and domoate, research on the structural components of ligand binding
and function in a variety of glutamate receptor types.had a slight effect on glutamate affinity, and markedly
increased AMPA sensitivity. In contrast, mutation of Previous site-mutation studies have used sequence ho-
mology with bacterial-binding proteins to localize aA689 selectively reduced kainate-binding affinity but
had no significant effect on the affinity for domoate, number of residues involved in ligand binding in AMPA
receptors (Uchino et al., 1992; Li et al., 1995), NMDAglutamate, or AMPA. We therefore conclude that these
Table 2. Binding Properties of GluR5, GluR6, R6(A689S), and R6(N721S)
Receptor [3H]Kainate Glutamate Domoate AMPA
GluR6
Lomeli et al., 1992 36 6 4.7 1080 6 100 8.6 6 1 .10,000
GluR6
This study 13.1 6 1.7 556 6 150 10.7 6 2.9 ..250,000
R6(A689S) 29.1 6 4.5 239 6 49 7.7 6 4.3 ..250,000
R6(N721S) 62.0 6 10.6 214 6 72 27.4 6 1.3 15,800 6 6000
GluR5
Lomeli et al., 1992 73 6 19 290 6 156 2.1 6 0.8 3000 6 1000
All receptors were expressed in HEK 293 cells, and binding properties were assayed as given in Experimental Procedures. Data from Lomeli
et al., 1992, for GluR5 and GluR6 is given for the purpose of comparison. Kainate values are mean KD 6 SEM and are given in nM. The Ki
values for glutamate, domoate, and AMPA are also in nM. For each mean KD or Ki value, the number of determinations in this study was either
three or four.
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receptors (Kuryatov et al., 1994; Wafford et al., 1995; R6(N721S) was greater than in GluR6; thus, the steady-
state to peak current ratio with 30 mM domoate was 0.19Hirai et al., 1996; Laube et al., 1997), and KBPs (Paas
et al., 1996; Wo and Oswald, 1996). In a systematic for R6(N721S) as compared to 0.42 for GluR6. The 3-fold
reduced domoate-binding affinity for the R6 (N721S)attempt to localize important binding domains in a func-
tional glutamate receptor, Stern-Bach and coworkers receptor is consistent with the increased rate of decay
of the currents after removal of domoate (see discussion(1994) constructed a series of GluR3-GluR6 chimeras
and assayed their pharmacological and binding proper- in Wong et al., 1994). It should be noted, however, that
in previous binding studies in HEK cells, the domoateties in Xenopus laevis oocytes. The agonist pharmacol-
ogy of their chimeras suggested residues in the N-termi- affinity for GluR5 was higher than that of GluR6 (Ki for
displacement of kainate 2.1 versus 8.6 nM, Lomeli etnal half of the S2 domain (S2N) were critical determinants
of AMPA sensitivity between AMPA and kainate recep- al., 1992). Thus, with respect to domoate binding,
R6(N721S) behaves less like GluR5 (i.e., the affinity istors. This interpretation was supported by an additional
study with cross-family chimeras, in which replacement lowered), whereas functionally this mutant exhibits
GluR5-like deactivation kinetics. Our results thereforeof the GluR2 S1 domain with a GluR6 S1 domain did
not appreciably change the AMPA EC50 of the resultant suggest that additional sites in these kainate receptors
stabilize the higher domoate affinity observed withchimera (Tygesen et al., 1995). We therefore tested
whether residues in the S2 domain might similarly con- GluR5.
The current study also provides clear functional sup-trol the differential low affinity AMPA sensitivity that dis-
tinguishes GluR5 and GluR6. The functional properties port for the importance of residues involved in kainate
binding in KBPs (Paas et al., 1996) and validate the latterof chimeras R6tm1R5 and R5tm1R6 (Figure2) supported
this idea, and we were further able to identify N721 as as useful constructs for modeling functional ionotropic
glutamate receptors. Paas and coworkers identifiedthe amino acid that eliminated AMPA sensitivity in GluR6
as compared to GluR5. In AMPA receptor subunits, a several residues in both the S1 and S2 domains that
accounted for the kainate-binding energy in these bind-threonine residue is conserved at the corresponding
site in the proteins. Preliminary experiments with an ing proteins, three of which are not conserved between
GluR5 and GluR6: T102, S267, and Y299. The first aminoadditional GluR6 mutant, R6(N721T), and a GluR4 AMPA
subunit mutant, R4(T708N), support the conclusions acid is in the S1 domain, while the latter two are in the
S2 domain and align with A689 and N721 in GluR6.drawn in the current study. AMPA evoked currents of
large amplitude from R6(N721T) (maximal currents at S267A and Y299A mutations in chick KBP reduced the
kainate-binding affinity by roughly 5-fold (Paas et al.,500 mM AMPA were as large as 92% of the peak gluta-
mate currents). Conversely, R4(T708N) showed reduced 1996). In similar mutants for GluR6, R6(A689S) exhibited
a 2-fold lower kainate-binding affinity compared tosensitivity to a number of agonists, including AMPA and
glutamate (G. T. S., unpublished data). Interestingly, GluR6, but no alterations in kainate displacement by
glutamate, domoate, or AMPA (see Figure 7 and Tablethreonine is also conserved in the high affinity kainate
receptor subunits KA-1 and KA-2, which coassemble 2). These binding data, when considered along with the
selective effect of mutant A689S on the kainate desensi-with GluR5 and GluR6. Heteromeric GluR6/KA-2 chan-
nels are sensitive to AMPA, which gates with low po- tization rate, strongly suggest that this residue is directly
involved in the binding of kainate but not the other ago-tency a nondesensitizing current (Herb et al., 1992). Our
results would suggest that the locus for this novel AMPA nists tested. In contrast, mutation of N721 in GluR6 al-
tered binding affinities of kainate, domoate, and AMPA,sensitivity conferred by KA-2 is T705. It is possible that
there are additional sites necessary for the higher affinity but had detectable functional effects solely on the re-
sponses to domoate and AMPA. Kainate-binding affini-AMPA binding, as has been proposed on the basis of
sequence alignments of GluR1 and GluR6 (Sutcliffe et ties for R6(N721S) were reduced by 5-fold compared to
GluR6, and the Ki value for domoate was decreased byal., 1996).
Previous studies have also indicated that residues 3-fold. Conversely, AMPA affinity was increased to a
detectable level (Ki 5 15 mM), although the sensitivitysomewhere within the S2 domain appear to control re-
ceptor sensitivity to the high affinity agonist domoate remained quite low (as is the case with GluR5; Sommer
et al., 1992).(Stern-Bach et al., 1994; Tygesen et al., 1995). This is
supported by the observation that a chimeric GluR6
receptor containing a GluR3 S2 domain [R6(R3S2)] had
A Model of the GluR6 S1-S2 Domains Based onan EC50 20-fold higher than that of wild-type GluR6
the Glutamine-Binding Protein Structure(Stern-Bach et al., 1994). In the present study, we have
Structure±function studies of ionotropic glutamate re-localized one S2 determinant of the functional response
ceptors have supported a model of the agonist-bindingto domoate in kainate receptors. Within the kainate re-
domain that uses the resolved structures of bacterialceptor family, there is also a significant difference in the
amino acid±binding proteins as archetypes. Nakanishidomoate potency of the nondesensitized (peak) currents
and coworkers first noted a degree of sequence similar-in GluR5 and GluR6. The peak EC50 for GluR5 has been
ity between the newly cloned AMPA receptor subunitsreported as 1.2 mM (Sommer et al., 1992), while that of
and the glutamine-binding protein (GlnBP) of Esche-GluR6 is unknown but likely to be .50 mM (G. T. S.,
richia coli (Nakanishi et al., 1990). At the time, AMPAunpublished data). Despite a clear effect on deacti-
receptors were thought to have four transmembrane-vation rates, the relative peak responses for domoate
spanning domains by analogy with other ligand-gatedversus glutamate or kainate were similar to those seen
with GluR6. However, the degree of desensitization in ion channels (Hollmann and Heinemann, 1994). This
Kainate Receptor Structure±Function
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has only weak similarity to ionotropic glutamate recep-
tors. Use of the GlnBP structure produced better initial
sequence alignments and should make our model closer
to the true GluR6 structure and therefore a more useful
predictive tool.
Consistent with our functional results, GluR6 A689
and N721 are localized to a helices lining the agonist-
binding pocket (Figure 8). Their appropriate localization
therefore lends support to the idea that these residues
form a direct interaction with ligands, rather than simply
disrupting the tertiary structure of the protein. Other
residues mutated in this study were distributed through-
out the structure and were located further from the bind-
ing pocket. Analogous residues (S267 and Y299) in the
chick KBP model based on LAOBP (Paas et al., 1996) are
also located near the binding pocket in that structure. In
the GluR6 model shown in Figure 8, S1 and S2 intertwine
to form a bilobate structure common to most of the
periplasmic binding proteins (Hsiao et al., 1996). The
ligand-binding pocket is formed by central cleft of z12
AÊ between the small and large lobes, which are con-
nected by a central ªhingeº region (Hsiao et al., 1996).
A number of residues, including those preceding S1 and
at the C-terminal end of S2, are not present in the model
in Figure 8 because they have no counterparts in GlnBP.
As has been noted previously (Paas et al., 1996), the
precise orientation of the bilobate structure with respect
Figure 8. A Model for the GluR6 S1-S2 Binding Domains Based on to the plasma membrane is uncertain because of these
the Resolved ªOpenº Structure of the Glutamine-Binding Protein extra unmodeled residues preceding M1 and M4.
(GlnBP) Crystallization of a number of bacterial periplasmic
This image was generated using the program SETOR (Evans, 1993). binding proteins in their liganded state has shown that
Secondary structure features are represented by flat ribbons (b
the two lobes move together upon agonist binding (Sackstrands) or coils (a helices). Regions with no corresponding amino
et al., 1989; Oh et al., 1993). A similar conformationalacid in GlnBP were modeled independently by the Swiss-Model
change has been proposed to occur in ionotropic gluta-server (see Experimental Procedures). The S1 and S2 domains are
colored blue and green, respectively. The side chains of A689 and mate receptors and to underlie functional phenomena
N721 are colored red; other amino acids that differ between GluR5 such as agonist trapping and desensitization (Benven-
and GluR6are shown colored yellow. The asterisk marks the putative iste and Mayer, 1995; Mano et al., 1996). In LAOBP,
agonist-binding cleft. The orientation of the structure with respect
whose structure has been solved in the open unligandedto the membrane is unknown.
and closed liganded states, agonist appears to bind to
the larger lobe first (Oh et al., 1993). Interestingly, Oh et
topology model placed the S1 and S2 domains on op- al. (1993) suggest that rotation about the hinge occurs
posite sides of the plasma membrane. However, sub- in the absence of ligand and that ligand binding primarily
sequent analysis of the N-glycosylation patternsof gold- stabilizes the closed structure due to favorable interac-
fish KBPs (Wo and Oswald, 1994), engineered sites in tions with the smaller lobe. If the binding domains of
GluR1 (Hollmann et al., 1994), and inserted glycosylation ionotropic glutamate receptors behave in a similar fash-
sites and epitope fusion in GluR3 (Bennett and Dingle- ion, our observation that mutation of an S2 amino acid,
dine, 1995) provided strong evidence for an alternate N721, produces a novel sensitivity to AMPA in GluR6
topology that modeled the classically defined M2 as a suggests that channel gating (i.e., functional activity)
reentrant loop. Concurrently with these studies, Stern- occurs only when the two lobes have stabilized in the
Bach et al. (1994) demonstrated that the regions of closed liganded state. Based on GluR1 site mutants, it
receptor homology with bacterial periplasmic-binding has been suggested that agonist binding to the larger
proteins were clearly involved in ligand binding in GluR3- lobe mediates channel opening, and interaction with the
GluR6 chimeras. smaller lobe produces desensitization (a ªvenus flytrapº
To understand better the roles of the residues we model; Mano et al., 1996). Our observations support an
mutated, we have generated a model of the GluR6 S1 alternative model in whichactivation and desensitization
and S2 domains based onthe recently publishedcrystal- are kinetic states entered into subsequent to lobe rota-
lographic structure of unliganded GlnBP (Figure 8) tion and agonist interaction with the smaller (predomi-
(Hsiao et al., 1996). Previously published models of the nantly S2) lobe.
glutamate receptor S1-S2 domains have relied on the Resolved structures for liganded GlnBP (in preliminary
structure of the lysine-arginine-ornithine binding protein form, Hsiao et al., 1996) and LAOBP (Oh et al., 1993)
(LAOBP) (Stern-Bach et al., 1994; Paas et al., 1996; Sut- and the extrapolated model for chick KBP (Paas et al.,
cliffe et al., 1996; Laube et al., 1997). While LAOBP 1996) support the interpretation that A689 and N721 in
GluR6 directly interact with glutamate receptor agonistsshares significant sequence homology with GlnBP, it
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were not a result of random mutations by the Pfu polymerase. Bothin the binding pocket. The residues that interact with
GluR6 and GluR5 cDNAs were contained in CMV promoter-con-glutamine in GlnBP were recently reported in a prelimi-
taining plasmids and had a glutamine at the Q/R editing site. GluR5nary form (Hsiao et al., 1996). Residue G119 of GlnBP,
was generously donated by Peter Seeburg and corresponded to
which aligns with A689 in GluR6, was shown to hydrogen the splice variant GluR5±2a from Sommer et al. (1992) (renamed
bond to the carboxyl group of glutamine. Interestingly, GluR5a in GenBank database). The GluR5a cDNA did not contain
the N-terminal insertion reported by Bettler et al. (1992). DNA se-this glycine residue bonds to glutamine through the
quencing of the cDNA verified this deviation from the GenBankbackbone nitrogen, which may explain why mutations
database sequence for GluR5a. Also, ten other nucleotide se-at this site in GluR6 (this paper) and cKBP (Paas et al.,
quences inthe GluR5±2a clone differed from the GenBank sequence1996) had no effect on the binding affinity or functional
for GluR5a; these mismatches do not affect the interpretation of our
response for glutamate. Furthermore, the observation current results.
that complementary mutations of this site (serine to ala-
Transfection and Electrophysiologynine in cKBP and alanine to serine in GluR6) both selec-
HEK 293 cells were maintained in DMEM media supplemented withtively reduce the kainate-binding affinity of GluR6 and
100 mg/ml penicillin, 100 mg/ml streptomycin, and 10% FCS. OnecKBP suggests that the side chain of this residue inter-
day before transfection, cells were split to low density on glass
acts with other sites on the receptor protein itself, rather coverslips coated with 100 mg/ml poly-D-lysine and collagen. Trans-
than directly with the ligand. With respect to N721 in fection of receptor cDNAs was by standard calcium-phosphate pre-
GluR6, the aligned residue in GlnBP does not directly cipitation with 1 mg cDNA per coverslip for 3±8 hr at 378C and 8%
CO2. All receptor subunits were cotransfected with a CD8 antigen-interact with glutamine (Hsiao et al., 1996). This again
containing plasmid (0.2 mg/coverslip). Electrophysiological record-is consistent with the model of cKBP based on LAOBP,
ings were made 1±3 days after transfection. To facilitate identifica-in which the complementary site affected kainate- but
tion of transfected cells, coverslips were incubated with polystyrene
not glutamate-binding affinity. beads coated with anti-CD8 antibody (Dynal Inc., Lake Success,
In summary, we have systematically examined the NY). Patch clamp recordings were made using an Axopatch 200B
amplifier (Axon Instruments, Foster City, CA). Patch electrodes wereroles played by S2 residues in generating divergent ago-
thick-walled borosilicate glass (Warner Instruments, Hamden, CT)nist responses in GluR5 and GluR6 kainate receptors.
and had a final resistance of 2±4 MV after fire polishing. The internalDetailed investigation of receptor kinetic properties al-
solution was composed of 110 mM CsF, 30 mM CsCl, 4 mM NaCl,
lowed us to identify functionally important amino acid 0.5 mM CaCl2, 10 mM HEPES, and 5 mM EGTA (adjusted to pH 7.3
residues. This information should prove useful in further with CsOH). The external bath solution contained 150 mM NaCl, 2.8
attempts to dissect out structural correlates of function mM KCl, 1.8 mM CaCl2, 1.0 mM MgCl2, and 10 mM HEPES (pH was
adjusted to 7.3 with NaOH). Drugs were applied through three-barrelin these receptors.
glass tubing (Vitro Dynamics, Rockaway, NJ) that had been pulled
to a internal barrel diameter of z80 mm and mounted on a piezo-
Experimental Procedures ceramic bimorph. The piezo bimorph was driven by TTL pulses from
pClamp 6.03 software (Axon Instruments) fed through a stimulation±
Construction of Chimeras and Site Mutants isolation unit (S-100, Winston Electronic Co., Millbrae,CA); rise times
The R6tm1R5 chimera was constructed using a PCR-based muta- of measured junction potential jumps were ,0.5 ms. Data were
tion protocol. The sense oligonucleotide primer for this chimera was acquired directly to a computer and were analyzed off-line using
based on the nucleotide sequence for amino acids 559±563 (LSPDI) pClamp software. Exponential decays were fitted with the Cheby-
from GluR6 followed by 564±571 (WMYVLLAC) from GluR5 and con- shev or Simplex least-squares algorithms in Clampfit.
tained a silent EcoRV site at the codon for amino acid 563. The
antisense primer was from nucleotides 2722±2749 of GluR5 and Membrane Preparation and Radioligand Binding Assays
contained a new XhoI site in the 39 untranslated region. The Membranes were prepared from ten 6 cm dishes, containing a total
C-terminal GluR5 fragment was generated by PCRwith the following of z1 3 107 cells, 48±72 hr after transfection. The cells were washed
conditions: 958C for 2 min; 35 cycles of 958C for 30 s, 558C for 30 twice with HEPES buffer (40 mM HEPES [pH 8.0], 100 mM NaCl)
s, and 758C for 2 min; with a final extension of 758C for 2 min. We prior to removal with a cell scraper. All subsequent steps were
used 900 ng of GluR5 plasmid DNA template, 150 pmol of each performed at 48C or on ice and using ice-cold buffers. The cells
primer, 200 mM dNTPS, and 2 U Vent polymerase (NEB, Beverly, were harvested at low speed (4,000 3 g for 15 min) and resuspended
MA). The PCR product was isolated from an agarose gel, digested in 5 ml HEPES buffer without NaCl. The cells were lysed with 20
with EcoRV and XhoI, and subcloned into the GluR6 cDNA cut at strokes in a hand-held Potter homogenizer and the membranes
the same restriction sites. Chimera R5tm1R6 and all site mutants recovered by centrifugation (100,000 3 g for 30 min). The homogeni-
were constructed using a modification of the Quikchange system zation and centrifugation steps were repeated a further two times.
(Stratagene, La Jolla, CA). Complementary oligonucleotide primers Membranes were resuspended in the same buffer and stored at
containing the site of mutation and a diagnostic silent restriction 2708C.
site were synthesized on-site or by Genset (La Jolla, CA). Repeated For all radioligand-binding experiments, samples were incubated
extensions of the entire plasmid template were carried out under in HEPES buffer (10 mM, pH 8.0) containing [3H]kainate (58 Ci/mmol,
the following conditions: 958C for 1 min and 20 cycles of 958C for NEN, Wilmington, DE) in a final volume of 0.5 ml for 1 hr at 08C.
30 s, 608C for 1.5 min, and 688C for 18 min with 100±300 ng template Nonspecific binding was defined as that not displaced by 100 mM
DNA, 125±250 ng each of primers, 250 mM dNTPs, and 2.5 U Pfu kainate. For competition studies, 10 nM [3H]kainate was used; con-
polymerase (Stratagene). A DpnI digest of the PCR mix was then centrations ranged from 1 to 200 nM in the saturation experiments.
carried out for 1.5 hr at 378C, and competent DH5a were transformed Bound and unbound radioligands were separated by vacuum filtra-
using standard procedures. For R5tm1R6, silent NheI sites were tion onto GF/C or GF/B filters (Whatman, Maidestone, UK), pre-
added by mutation of nucleotides 1783 in GluR5 and 2013 in GluR6. soaked for 1 hr in 0.1% polyethyleneimine (RBI, Natick, MA), fol-
The NheI-XbaI fragment of GluR6 was then subcloned into the same lowed by two 4 ml washes in ice-cold HEPES buffer. All assays
sites in GluR5 to create R5tm1R6. For site mutants, screening of were performed in triplicate. Results from saturation experiments
candidate mutants was carried out by restriction digest with a diag- were analyzed using Scatchard transformations, and competition
nostic enzyme or by direct dideoxy sequencing. All positive site curves were fitted to the Hill equation.
mutants and chimeras were sequenced in the region of interest to
confirm the mutation. The entire coding regions of a number of Generation of GluR6 S1-S2 Model
clones [R6(A689S), R6(N721S), R6(F735L), R6(689/721), R5(S689A), A sequence alignment between E. coli GlnH and rat GluR6 was
initially generated in a multiple alignment with the rat GluR1-GluR5,and R5(S721N)] were sequenced to ensure that functional changes
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GluR7, NMDAR1, and NMDAR2a sequences using the PILEUP pro- Herb, A., Burnashev, N., Werner, P., Sakmann, B., Wisden, W., and
Seeburg, P.H. (1992). The KA-2 subunit of excitatory amino acidgram from the University of Wisconsin GCG software package. This
receptors shows widespread expression in brain and forms ioninitial alignment was optimized manually. Two stretches of GluR6,
channels with distantly related subunits. Neuron 8, 775±785.S432 to G547 and P667 to G801, were minimally required to align
with GlnH and were used to build the model. Model construction Hirai, H., Kirsch, J., Laube, B., Betz, H., and Kuhse, J. (1996). The
was performed in a two-step process by the Swiss-Model server glycine binding site of the N-methyl-D-aspartate receptor subunit
(http://www.expasy.ch; Peitsch, 1996) using the interface provided NR1: identification of novel determinants of coagonist potentiation
by the Swiss-PDBViewer program (available from the same site). In in the extracellular M3-M4 loop region. Proc. Natl. Acad. Sci. USA
the first step, the truncated GluR6 sequence was compared to a 93, 6031±6036.
database of structures to find suitably homologous proteins. The Hollmann, M., and Heinemann, S. (1994). Cloned glutamate recep-
only template returned by the server was that of GlnH (PDB acces- tors. Annu. Rev. Neurosci. 17, 31±108.
sion 1ggg). The GluR6 sequence was then threaded into the GlnH
Hollmann, M., Maron, C., and Heinemann, S. (1994). N-glycosylationstructure using the Swiss-PDBViewer application and the alignment
site tagging suggests a three transmembrane domain topology for
obtained previously. Gaps were inserted into the GlnH sequence at
the glutamate receptor GluR1. Neuron 13, 1331±1343.
six points to obtain an optimal alignment. The GluR6 sequences
Hsiao, C.-D.,Sun, Y.-J., Rose, J., and Wang, B.-C. (1996). The crystalunaligned as a consequence were from 568±577, 603±615, 677±680,
structure of glutamine-binding protein from Escherichia coli. J. Mol.699±713, 732, and 739. The Swiss-Model server modeled these
Biol. 262, 225±242.sequences independently. With theexception of residue S739, these
KoÈ hler, M., Burnashev, N., Sakmann, B., and Seeburg, P.H. (1993).regions were distal from the putative agonist-binding site. Three of
Determinants of Ca21 permeability in both TM1 and TM2 of highthe loops (677±680, 699±713, and 732) were at the base of the
affinity kainate receptor channels: diversity by RNA editing. Neuronstructure, where S1 ends and S2 starts. It is this region of the
10, 491±500.receptor through which agonist binding is likely to be communicated
to the receptor pore. This initial model was sent to the server for Kuryatov, A., Laube, B., Betz, H., and Kuhse, J. (1994). Mutational
refinement and the building of loop regions. The final model was analysis of the glycine-binding site of the NMDA receptor: structural
returned from the server in the form of a pdb file. similarity with bacterial amino acid-binding proteins. Neuron 12,
1291±1300.
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